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Abstract 
Background: Rupture of an intracranial aneurysm (IA) causes a systemic response that involves an immune/inflam-
matory reaction. Our previous study revealed a downregulation of genes related to T lymphocytes and an upregula-
tion of genes related to monocytes and neutrophils after IA rupture. It remains unknown whether that resulted from 
alterations in transcription or cell count. We sought to characterize the systemic response to IA rupture through 
analysis of transcript expression profiles in peripheral blood cells. We also investigated effects of IA rupture on the 
composition of mononuclear cells in peripheral blood.
Methods: We included 19 patients in the acute phase of IA rupture (RAA, first 72 h), 20 patients in the chronic phase 
(RAC, 3–15 months), and 20 controls. Using deep transcriptome sequencing, we analyzed the expression of protein-
coding and noncoding RNAs. Expression levels, transcript biotypes, alternative splicing and other features of the 
regulated transcripts were studied. A functional analysis was performed to determine overrepresented ontological 
groups among gene expression profiles. Flow cytometry was used to analyze alterations in the level of mononuclear 
leukocyte subpopulations.
Results: Comparing RAA and controls, we identified 491 differentially expressed transcripts (303 were downregu-
lated, and 188 were upregulated in RAA). The results indicate that the molecular changes in response to IA rupture 
occur at the level of individual transcripts. Functional analysis revealed that the most impacted biological processes 
are related to regulation of lymphocyte activation and toll-like receptor signaling pathway. Differences between RAC 
and controls were less prominent. Analysis of leukocyte subsets revealed a significantly decreased number of CD4+ 
lymphocytes and increase of classical and intermediate monocytes in RAA patients compared to controls.
Conclusions: IA rupture in the acute phase strongly influences the transcription profiles of peripheral blood cells as 
well as the composition of mononuclear cells. A specific pattern of gene expression alteration was found, suggesting 
a depression of lymphocyte response and enhancement of monocyte activity.
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Background
Rupture of an intracranial aneurysm (IA) causes suba-
rachnoid hemorrhage (SAH), which is burdened with 
high mortality and high disability rates [1, 2]. This poor 
prognosis is driven by direct neurological sequels of 
IA rupture and systemic complications resulting from 
bed-ridden patient status and infections. The latter are 
associated with immunodepression related to central 
nervous system acute injury [3, 4]. Molecular mecha-
nisms underlying systemic responses to SAH remain 
poorly characterized. A range of changes in levels of dif-
ferent molecules, blood cells counts and their function in 
peripheral blood was reported [5–7].
Using a microarray approach, we previously showed 
that IA rupture influences the transcriptional pro-
files of peripheral blood cells, and the pattern of these 
changes suggests a depression in lymphocyte response 
with enhancements in monocyte and neutrophil activi-
ties [8]. In patients with poor outcomes, the differences 
in levels of cell-related transcripts were significantly 
more prominent. However, whether observed changes 
in genes transcriptions reflected changes in blood cell 
counts, cell activation levels or both remained open. 
There is an increasing body of evidence that SAH is asso-
ciated with a dysregulation of lymphocyte subsets [9–11] 
and—particularly in patients with SAH-related complica-
tions—there are significant changes in lymphocyte and 
monocyte counts and functions [5]. Studies on ischemic 
stroke also showed its strong influence on the number 
and activity of monocyte and lymphocyte subclasses and 
their associations with clinical course [12, 13].
In the current study, we sought to investigate the sys-
temic effects of aneurysmal SAH through analysis of 
gene expression profiles in peripheral blood cells using 
deep transcriptome sequencing. We performed a global 
analysis of protein coding and noncoding gene variants 
regulated by SAH. We also investigated the expression 
of specific gene variants that may lead to production of 
functionally distinct protein isoforms and influence sys-
temic response to IA rupture. Moreover, we analyzed 
subpopulations of mononuclear leukocytes in peripheral 
blood after IA rupture. These SAH-related changes were 
evaluated both in the acute and in the chronic phase and 
were compared with the changes in control subjects.
Methods
Patients
Consecutive patients with aneurysmal SAH were pro-
spectively recruited in University Hospital, Krakow in 
2014 and 2015. Patients with head trauma, vasculitis, 
arteriovenous malformations, hematological disorders, 
and known malignancies were excluded. Two inde-
pendent patients groups were analyzed: acute (first 72 h 
after IA rupture) and chronic (3–15 months after SAH). 
Control subjects (C) were recruited from patients who 
suffered from headaches. All subjects were Caucasian. 
Informed consent was obtained from all participants (or 
their guardians). The local ethics committee approved 
the study. Differences between groups were analyzed 
using χ2 and Fisher exact tests or Mann–Whitney U test 
where appropriate, p < 0.05 was considered statistically 
significant.
Blood collection and RNA extraction
Venous whole blood was collected before neurosurgical 
or endovascular interventions in PAXgene Blood RNA 
Tubes (PreAnalytiX, GmbH, Switzerland). Total RNA 
was isolated using PAXgene Blood RNA Kit (PreAna-
lytiX) following the manufacturer’s protocol. RNA con-
centrations were measured using a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, Montcha-
nin, DE), and RNA quality was determined by chip-based 
capillary electrophoresis utilizing an RNA 6000 Nano 
LabChip Kit and an Agilent Bioanalyzer 2100 (Agilent, 
Palo Alto, CA).
Whole‑transcriptome sequencing
Before library generation with TrueSeq Stranded Total 
RNA Library Prep (Illumina, San Diego, CA), riboso-
mal RNA was removed with Globin-Zero Gold Removal 
Kit (Illumina). Whole transcriptome libraries were 
sequenced on a HiSeq 4000™ (Illumina) with the fol-
lowing parameters: PE 150 (paired ends) and 45 M clean 
reads which gave a minimum of 13.5 Gb of raw data per 
sample. The RNA-seq data were submitted to the NCBI 
Sequence Read Archive (SRA): SRP150595.
RNA‑seq data analysis and transcript classification
The quality of NGS data was verified using FastQC. The 
RNA-seq reads were aligned to GRCh37.p13 using Hisat2 
2.0.5. The transcript FPKM (Fragments Per Kilobase of 
transcript per Million fragments mapped) levels were 
quantified using the Cufflinks v2.2.1 and GTF from the 
Ensembl gene database. Statistical significance was ana-
lyzed using one-way analysis of variance (ANOVA) on 
 log2(1 + x) values which have normal continuous distri-
bution [14]. The false discovery rate (FDR) was estimated 
using the Benjamini–Hochberg method. All statistical 
analyses were performed using R software v3.4.3. Tran-
script annotation and classification was performed using 
the BioMart interface for the Ensembl gene database.
Functional classification of differentially expressed genes
The gene annotation tool Enrichr was used to iden-
tify overrepresented ontological groups among the 
gene expression patterns and to group the genes into 
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functional classifications [15]. Overrepresented terms 
(Wiki Pathways 2016) were defined as having at least 
three transcripts and p < 0.05 per Fisher’s exact test. For 
cell-type enrichment of mRNA, the Enrichr cell types 
(Human Gene Atlas) module was used. The identifica-
tion of overrepresented transcription factor binding sites 
(TFBSs) in the regulatory regions of genes was performed 
using the ChIP-seq data (ChIP Enrichment Analysis, 
ChEA2016) module implemented in the Enrichr online 
resource. Gene symbol lists were submitted, and default 
parameters were used.
Validation of NGS results using quantitative PCR (qPCR)
Reverse transcription was performed using Omniscript 
Reverse Transcriptase (Qiagen Inc.). The qPCR reactions 
were performed using isoform specific  TaqMan® probes 
or designed by the Custom  TaqMan® Assay Design Tool 
(Life Technologies) and were run on the CFX96 Real-
Time system (BioRad). Overall, 17 qPCR assays for 8 
genes (HEATR1, ACBD6, CCND2, PLEKHA1, ELF2, 
CFLAR, TRAF1 and PPP1R16B) have been used. The 
list of assays including target transcripts is presented in 
Additional file  1: Table  S1. Expression of the hypoxan-
thine–guanine phosphoribosyltransferase 1 (HPRT1) 
transcript was quantified to control for variations in 
cDNA concentrations. The abundance of each RNA was 
calculated as  2−(threshold cycle). Data were analyzed using 
one-way ANOVA followed by Tukey’s multiple compari-
sons test.
L/MN index
A lymphocyte-to-monocyte-and-neutrophil index (L/
MN index) was measured as previously described [8]. 
Based on RNAseq results, the L/MN index was calculated 
as the ratio of the mean folds of standardized expression 
levels of lymphocyte-related genes (BCL11B, CCR7, CD2, 
CD27, CD3D, CD3E, CD8A, and KLRB1) to those of 
monocyte-and-neutrophil-related genes (ANXA3, ARG1, 
CD14, GYG1, FCGR1A, FCGR2A, IRAK3, and MMP9). 
The abundance levels of the specific IA-altered tran-
scriptional variants of the selected genes were used in the 
analysis (Additional file 2: Table S2). T-tests with Welch’s 
correction were performed on L/MN values between the 
groups of patients.
Analysis of subsets of mononuclear leukocytes by flow 
cytometry
Blood was collected in EDTA-tubes in the morning after 
admission. White blood cell (WBC) count and differen-
tial were determined by the clinical laboratory. Mono-
cyte and lymphocyte subpopulations were analyzed in 
whole blood by flow cytometry using BD FACSCanto II 
with Diva software v 6.1.2 (BD Biosciences San Jose, CA). 
Blood samples were incubated with a premixed antibody 
cocktail for 15  min, then erythrocytes were lysed with 
BD FACS Lysing Solution (BD Biosciences). The follow-
ing fluorochrome-conjugated monoclonal antibodies 
were used (all antibodies were mouse IgG1): FITC-CD14 
(MφP9; BD Biosciences), PE-CD16 (3G8; Beckman Coul-
ter, Miami, FL), PC5-CD3 (UCHT1; Beckman Coulter), 
FITC-CD4 (SK3; BD Biosciences), PE-CD8 (SK1; BD 
Biosciences), PC5-CD33 (D3HL60,251; Beckman Coul-
ter), and invariant natural killer T (iNKT) Cell (6B11; 
BD Pharmingen, San Jose, CA). Antibody-capture beads 
(CompBeads, BD Biosciences) were used for single-color 
compensation controls for each reagent used in the study. 
Lymphocyte and monocyte subsets were identified based 
on forward scatter (FSC) vs side scatter (SSC) and posi-
tive expression of their respective markers. Absolute 
numbers of lymphocyte and monocyte subsets were 
calculated by multiplying the total WBC with the total 
percentage of each cell population. First, we excluded 
doublets using FSC area vs FSC height and analyzed only 
singlets. Lymphocyte populations were analyzed by gat-
ing using FSC and SSC. The lymphocyte T-population 
was analyzed by gating CD3+ cells and on the next dot 
plot—SSC vs CD3. From this gate, T lymphocytes were 
selected and further divided into: CD4+CD8−, CD4−
CD8+, CD4+CD8+, and CD4−CD8− lymphocytes. 
In addition, using an anti-iNKT cell antibody, we iden-
tified CD3+ iNKT cells. Monocyte populations were 
analyzed by gating using FSC and SSC. Next, from the 
CD33+ and CD14+ cell gate and the gate on the SSC vs 
CD14 dot plot, we extracted the monocyte population. 
On the next dot plot (CD14 vs CD16), three monocyte 
subsets were distinguished: CD14++CD16− (classical), 
CD14++CD16+ (intermediate), and CD14+CD16++ 
(nonclassical).
Results
Profile of transcriptomic alterations induced by IA rupture
The study comprised 19 patients in the acute phase of 
SAH (RAA), 20 patients in the chronic phase (RAC), 
and 20 control subjects. Their clinical characteristics are 
summarized in Table  1. In 8 patients ruptured IA was 
closed by clipping, in remaining 11—by coiling. During 
hospitalizations, among RAA patients we noticed: one 
patient developed symptomatic vasospasm, 1 rebled and 
required external drainage, 1 had urinary tract infection, 
1—bronchitis with subsequent pneumonia, 1—pneumo-
nia accompanied by heart failure, and 1 who developed 
sepsis and multiorgan failure. Two latter patients died. 
Transcriptional patterns found in these patients did not 
differ significantly from the rest of the RAA group, and 
their exclusion (as a subgroup or individually) from the 
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analyses did not influenced significantly obtained results. 
Also the same was true for the cell subsets analyses.
We used NGS to examine gene expression at the level 
of specific transcriptional units. We measured FPKM for 
all the transcripts annotated in the GRCm38.p13 genome 
release using the Cufflinks package. A total of 94,239 
transcripts corresponding to 35,529 annotated genes 
were detected at the threshold of FPKM ≥ 0.1.
The regulated transcripts were identified by one-way 
ANOVA with clinical status (RAA, RAC, C) as the fac-
tor. There were 491 differentially expressed transcripts 
(FDR < 0.001%). Comparing RAA and C groups, we found 
403 differentially expressed transcripts (177 up- and 226 
downregulated in RAA patients, fold change > 2). No sig-
nificant differences were observed between RAC and C 
groups, and differences between RAA and RAC patients 
were noted for 268 transcripts (178 up- and 290 down-
regulated in RAA, fold change > 2). As blood samples 
from the RAC patients were obtained at different time 
points after IA rupture, we investigated the potential 
effects of the time lapse on gene expression profiles. We 
found two significant relationships (Spearman’s rank cor-
relation coefficient R > 0.7, p < 0.01) between the time 
after SAH onset and the transcript expression levels. 
Both SLC26A8 (ENST00000486155) and BASP1-AS1 
(ENST00000399760) were upregulated after IA rupture, 
and the level of transcript abundance decreased over 
time towards control levels (Additional file 3: Figure S1). 
The full list of regulated transcripts is presented in Addi-
tional file 4: Table S3.
Functional annotations of the regulated transcripts
Hierarchical clustering revealed two major gene tran-
scription patterns in peripheral blood associated with 
IA rupture (arbitrarily described as A–B; Fig. 1a). These 
two groups revealed opposite patterns of up- and down-
regulated gene expression levels. Transcripts from 
the first cluster (303) showed decreased abundance in 
response to SAH. The second cluster includes genes 
(186) upregulated after IA rupture. Genes from each 
pattern were analyzed by the GO BP terms and Wiki 
Pathways 2016 categories. Functional analysis of the 
downregulated genes showed that the most overrepre-
sented biological processes are those related to positive 
leukocyte activation (GO:0002694) and T cell differentia-
tion (GO:0042110). Among Wiki pathways, those related 
to T-cell receptor signaling, inflammatory response and 
ribosomal proteins were enriched in the regulated genes. 
Examples of transcripts clustered to this group included 
CD28, ITK and ZAP70. Among the genes with increased 
mRNA abundance levels, transcripts connected with 
Toll-like receptor signaling pathway (GO:0002224) and 
activation of inflammatory response (GO:0006954) were 
overrepresented. Analysis of this pattern also revealed 
the enrichment of genes involved in IL1 and IL4 signaling 
pathways, including IL1R1, IL1R and IRAK3.
To investigate the mechanisms of transcriptional altera-
tions in response to IA rupture, we searched for overrep-
resented transcription factor binding sites (TFBSs) in the 
regulatory regions of coexpressed transcripts. We exploited 
available ChIP-seq data (ChIP Enrichment Analysis, ChEA) 
Table 1 Clinical characteristics of the patients
RAA acute phase of intracranial aneurysm (IA) rupture, RAC chronic phase of IA rupture, C control subjects, IQR interquartile range, GCS Glasgow Coma Scale, WFNS 
World Federation of Neurological Surgeons
RAA (n = 19) RAC (n = 20) C (n = 20) p RAA vs RAC p RAA vs C p RAC vs C
Median age (IQR), years 54 (48–62) 50 (41–56) 55 (50–60) n.s. n.s. n.s.
Female, % 73.7 90.0 55.5 n.s. n.s. 0.03
Hypertension, % 57.9 55.0 50.0 n.s. n.s. n.s.
Smoking, % 31.6 40.0 30.0 n.s. n.s. n.s.
Excessive drinking, % 0 5.0 10.0 n.s. n.s. n.s.
Aneurysms location
 Anterior circulation 17 16 –
 Posterior circulation 2 4 –
Aneurysms number (number of patients)
 1 13 9 –
 2 6 9 –
 3 0 2 –
Admission Hunt-Hess score (IQR) 2 (1–3) – –
Admission GCS score (IQR) 15 (13–15) – –
Admission WFNS score (IQR) 1 (1–3) – –
Admission modified Fisher Scale (IQR) 3 (1–3) – –
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using the module implemented in the Enrichr online 
resource. Promoters of downregulated transcripts exhibited 
a significant overrepresentation in the ChIP-seq signal for 
several transcriptional factors, including STAT6 (adjusted 
p = 7 × 10−8, ChEA: “STAT6_20620947_ChIP-Seq_CD4_
POS_T_Human”) and RUNX (adjusted p = 7.3 × 10−7, 
ChEA: “RUNX_20019798_ChIP-Seq_JUKART_Human”). 
Genes with increased mRNA abundance levels had a 
different set of putative transcriptional regulator bind-
ing sites, including ELF2 (adjusted p = 0.01, ChEA: 
“Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse”) 
and SMRT (adjusted p = 0.01, ChEA: “SMRT_22465074_
ChIP-Seq_MACROPHAGES_Mouse”) (Fig. 1b).
Identification of cell types expressing genes in patterns 
A and B was carried out in reference to the Human Gene 
Atlas. A highly significant enrichment of transcripts from 
the pattern A are found in CD4+ (adjusted p = 1.9 × 10−13) 
and CD8+  T-cells (adjusted p = 3.8 × 10−12). Enriched 
transcripts from pattern B are found in the whole-blood 
(adjusted p = 1.2 × 10−24) and CD33+ myeloid cells 
(adjusted p = 2.2 × 10−5) (Fig. 1b). Details about functional 
classification, overrepresented TFBSs and cell-type enrich-
ment are provided in Additional file 5: Table S4.
Identification and classification of the altered 
transcriptional variants
To determine the diversity in the blood transcriptome, we 
classified the identified coding and noncoding transcripts 
by using 29 known biotypes (based on Vega annotation; 
Additional file 4: Table S3). 72.5% of the regulated tran-
scripts were protein coding, compared with 50.2% of the 
transcripts expressed (FPKM > 0.5) at basal conditions 
(Fig. 2). The majority of noncoding, regulated transcripts 
were classified as retained intron (10.4%) and processed 
transcripts (5.7%) (vs 21.7% and 12% at basal conditions, 
respectively). Therefore, we further studied pre-mRNA 
levels of the genes altered in the RAA group. We com-
pared the number of reads aligned to either exons or 
introns of the up- and downregulated genes. We found 
a pronounced decrease in the exon/intron ratio score for 
the downregulated genes.
The classifications of transcription alterations indicated 
different types of alternative expression of the differen-
tially expressed genes. The analyses at the levels of gene 
isoforms, alternative exon splicing and alternative pro-
moter usage were done by using Cuffdiff. We found 148 
specific gene isoforms (annotated to 120 genes) altered in 
Fig. 1 Profiling of transcriptional alterations in the peripheral blood cells of patients after IA rupture. a Hierarchical clustering of transcripts 
regulated in response to IA rupture. RNA-seq results are shown as a heat map and include 491 transcripts with a genome-wide significance 
(FDR < 0.01%) from one-way ANOVA for the factor of clinical status. Gene transcripts with altered RNA abundance levels are listed in Additional 
file 4: Table S3. Colored rectangles represent transcript abundance measured in the samples described above (RAA: acute phase of IA rupture, 
RAC: chronic phase of IA rupture, C: healthy controls). The intensity of the color is proportional to the standardized values (between −4 and 4) 
from each RNA-seq measurement, as indicated on the bar below the heat map image. Hierarchical clustering was performed with the R software 
using distance metric—correlation and the average linkage method. Two major gene transcription patterns in peripheral blood associated with IA 
rupture were arbitrarily denoted as A and B. Changes in the expression of six example genes (labeled on the right) were analyzed by using qPCR. 
b The analysis of gene expression patterns using data-mining methods. Functional enrichment among genes with similar expression profiles was 
identified by using the Enrichr analysis tool. Overrepresentation of functional links, TFBSs and expression in the particular cell types were indicated 
on the right. The examples of functional enrichment were indicated, and the complete results of the analysis are presented in Additional file 5: 
Table S4
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response to IA rupture (corrected p < 0.01, fold > 4). The 
majority of the transcripts differed between RAA and C 
(132) as well as RAA and RAC (125). Only 2 transcrip-
tional isoforms (of DEFA3 and IFI27) showed different 
levels between RAC and C groups. We did not find any 
statistically significant differences in alternative splicing 
or alternative promotors after the correction for number 
of tests performed (Additional file 6: Table S5).
Validation of the alternative expression of genes
We used qPCR to validate the results obtained by NGS. 
From 491 transcripts regulated after IA rupture, we 
selected 8 potential examples of isoform-specific gene 
expression (identified by Ensembl Transcript ID). The 
selected genes (Additional file  1: Table  S1) were charac-
terized by different profiles of regulation of the particu-
lar isoforms, each of the analyzed transcripts contains 
unique exons and a mean mRNA abundance level > 4 
FPKM. The changes were measured using custom TaqMan 
assays designed to detect specific transcriptional vari-
ants. We found significantly different levels of expression 
for isoforms of HEATR1 (ENST00000366582), ACBD6 
(ENST00000367595), CCND2 (ENST00000261254), PLE-
KHA1 (ENST00000368990), ELF2 (ENST00000511184 
and ENST00000510408), and CFLAR (ENST00000342795, 
ENST00000425030 and ENST00000309955). Opposite 
profiles of regulation between different isoforms of the 
same gene were revealed for HEATR1, ACBD6 and ELF2 
(Fig.  3). In the cases of PLEKHA1 and CFLAR, all ana-
lyzed variants showed similar regulation in response to 
IA rupture. For CCND2, only one TaqMan assay worked, 
and the results confirmed the downregulation detected 
by NGS. For TRAF1 (ENST00000373887) and PPP1R16B 
(ENST00000299824) alteration profiles were similar to 
those obtained by RNA-seq but not statistically significant. 
Alterations in the expression of specific gene isoforms in 
response to IA rupture were reproducible.
Effects of IAs rupture on subsets of peripheral 
mononuclear cells
In the acute phase of SAH, we found a significant 
increase in the total monocyte count compared to the 
chronic phase (p < 0.01). Among RAA patients compared 
to controls, the classical monocyte count was higher 
and, in comparison to RAC, both classical and interme-
diate monocyte counts were higher. The proportions of 
subsets also differed between the studied groups: among 
RAA subjects, the percentage of nonclassical monocytes 
was lower in comparison to controls, but the percent-
age of intermediate monocytes was higher compared to 
RAC patients. We did not observe significant differences 
between RAC and C groups (Fig. 4a). Dynamic changes 
were also observed in lymphocyte population.
Namely, their total count was lower in the acute phase 
of SAH compared to controls and the remote phase 
(p < 0.01). The same was true for CD3+ (T-lymphocytes) 
as well as CD4+ and CD8+ subsets. Among the inves-
tigated lymphocyte subpopulations, only the CD4+ per-
centage dropped significantly in acute SAH in relation to 
the remaining groups. Moreover, the CD4+/CD8+ ratio 
was significantly lower among RAA patients compared to 
controls (1.96 vs 2.66, respectively, p < 0.03) (Fig. 4b). The 
differences in the levels of lymphocytes were associated 
with the clinical outcome of the patients. The comparison 
of patients with Glasgow Outcome Scale scores of 4–5 vs 
1–3 points indicated that lymphocytopenia is associated 
with a worse prognosis (p < 0.05). We did not observe any 
significant alterations in iNKT cell count (not shown).
To solve the question of whether observed changes 
in transcription levels are only related to the number of 
Fig. 2 Distribution of biotypes among the transcripts altered in response to IA rupture. The charts presenting the proportion of transcripts biotypes 
at basal level (all the detected transcripts, FPKM < 0.5) and in response to IA rupture (regulated transcripts). The transcripts identified using RNAseq 
were classified using 29 known biotypes (based on Vega annotation; Additional file 4: Table S3)
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cellular sources, we analyzed alterations in cell-type spe-
cific transcripts. The transcripts specifically expressed 
in CD4+ and CD14+ cell populations were identified 
by using the mRNA abundance levels obtained from 
the BioGPS database (Human U133A/GNF1H GeneAt-
las dataset). At the cellular level, the monocyte count 
increased 1.3-fold in RAA vs C subjects, whereas the 
CD14+-enriched transcripts showed a 1.8- to 4.6-fold 
increase in the RAA group. The CD4+ count was 1.5-
fold lower in RAA vs C patients with a twofold drop in 
CD4+-enriched transcript levels. This could suggest that 
the observed changes in T cell-specific transcripts (at 
least CD4+) are mainly driven by cell number, whereas 
monocyte transcription is actively regulated in response 
to the pathological process.
L/MN index
We tested a previously proposed L/MN index to evaluate 
prognosis in RAA patients [6]. The mean L/MN value was 
significantly higher in C compared with RAA patients 
(0.78 vs 0.24, respectively; p = 2.16E−10). The L/MN index 
was also associated with SAH severity: its value was sig-
nificantly higher among RAA patients scored at 14–15 
points on the Glasgow Coma Scale at admission com-
pared with RAA patients scored at 3–13 points (0.26 vs 
0.15, respectively; p < 0.05). When compared 2 patients 
who died with those who survived (n = 17), we observed 
nominally lower L/MN index among those with the worst 
outcome. However, the difference was not statistically 
significant. The mean L/MN index was insignificantly 
higher in RAC patients compared to C (0.88).
Discussion
Rupture of an IA, particularly in the acute phase, causes 
noticeable changes in the composition of peripheral 
blood cells and their transcription profiles. The pre-
sented results suggest a depression of lymphocyte 
response and an enhancement of pro-inflammatory 
Fig. 3 Validation of gene isoform-specific transcriptional alterations induced in response to IA rupture in peripheral blood. The expressions of 
HEATR1, ACBD6 and ELF2 transcripts were measured (Ensembl transcripts IDs are presented in the middle). qPCR analyses were performed to 
confirm isoform specific regulation using the same samples (n = 11–14). TaqMan probes allow for distinguishing between specific transcriptional 
variants. The assay locations are indicated by yellow lines. Bars indicate S.E.M, #p < 0.05 from one-way ANOVA (factor of clinical status) followed by 
Tukey’s multiple comparisons test to identify differences between the groups (*p < 0.05, **p < 0.01)
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monocyte activity. These effects are no longer detecta-
ble several months after IA rupture. Similarly, van’t Hof 
et  al. did not detect any significant alterations in gene 
expression profiles in blood cells among SAH survivors 
investigated years after IA rupture [16].
The analysis of transcription profiles revealed an 
increased abundance of transcripts related to activation 
of inflammatory response, Toll-like receptor signaling, 
and activation of innate immunity with a concomitant 
downregulation of transcripts related to positive leu-
kocyte activation, T-cell differentiation and CD4+ and 
CD8+ lymphocytes. This is in line with our earlier find-
ings [8]. Moreover, we confirmed that the previously 
proposed L/MN index (based on expression levels of 
lymphocyte-, monocyte- and neutrophil-related genes) 
is significantly lower in patients with SAH early after IA 
rupture compared to control subjects. A similar direction 
of changes was observed at the cellular level.
In acute SAH, the increase in overall monocyte count 
seemed to be driven mainly by the increased classical 
monocyte count. Similar changes were reported in myo-
cardial infarction [17]. Analysis of the proportions of 
monocyte subsets showed that early after IA rupture, the 
percentage of classical monocytes did not change sub-
stantially, whereas the percentage of intermediate mono-
cytes increased compared with controls, and nonclassical 
dropped compared to the chronic phase. These altera-
tions resembled previously published observations [12]. 
The existing data regarding the influence of IA rupture 
on monocytes are conflicting. Both an increased count 
and activation of monocytes [18] as well as a lack of any 
significant changes were reported [6]. Our results suggest 
that in acute SAH, the number of monocytes increases 
Fig. 4 Effects of IA rupture on subsets of peripheral mononuclear cells. a Changes in count and proportions of monocytes and their subsets; b 
changes in count and proportions of lymphocytes and their subsets. Data are presented as medians and interquartile ranges. *p < 0.05 (Mann–
Whitney U test)
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with a preferential increase in classical monocyte count 
and—looking at the subset proportions—a decrease in 
nonclassical monocytes. Similar findings were reported 
in acute ischemic stroke [13]. In an experimental model, 
ischemic stroke was shown to enhance monocyte pro-
duction by bone marrow stem cells [19, 20]. In humans, 
systemic inflammation caused release of classical mono-
cytes from bone marrow and their subsequent matura-
tion into intermediate and nonclassical cells [21]. Existing 
data suggest that classical monocytes first react to an 
inflammatory challenge and then they can mature into 
pro- or anti-inflammatory cells. The results of this study 
also suggest that IA ruptures elicit similar effects, i.e., 
release of classical monocytes followed by their transfor-
mation into other subclasses.
Simultaneously, we noticed significantly decreased 
levels of both CD4+ and CD8+ T-lymphocytes. A 
decrease in the CD3+ cell count within 24 h of IA rup-
ture was previously reported [12]. However, CD4+ and 
CD8+ numbers did not differ significantly between the 
aneurysmal SAH subjects and controls. In the acute 
phase of other types of stroke, i.e., intracerebral hemor-
rhage and brain infarction, a decrease was found in the 
total lymphocyte count and in counts for the CD3+, 
CD4+, and CD8+ subsets [22, 23]. Decreased numbers 
of T-lymphocytes correlated with poor initial clinical sta-
tus and worse outcomes, in different types of stroke [5, 
11, 22–25]. Additionally, the analysis of TFBSs pointed at 
the shift towards pro-inflammatory reaction and deregu-
lation of T-cells in the acute phase of SAH. Among the 
promoters of downregulated transcripts, we found signif-
icant overrepresentation for STAT6 and RUNX. In mono-
cytes, STAT6 plays an important role in transcription of 
anti-inflammatory genes [26]. Runx proteins are critical 
for differentiation and function of CD4+ and CD8+ lym-
phocytes [27]. Lack of changes in the iNKT cell count 
after ischemic stroke was previously reported [28].
The systemic response to SAH is clearly a dynamic 
process. IA rupture predominantly evoked alterations 
in protein-coding transcripts. Interestingly, analysis of 
pre-mRNAs of differentially expressed genes in the acute 
phase revealed a lower exon/intron ratio among down-
regulated transcripts. This could suggest an attempt to 
enhance expression of genes whose total levels dropped 
due to a decreased number of cells from which they 
originate (probably T-cells). For a considerable subset 
of genes, we were able to identify alternatively spliced 
isoforms. Most of them were unique for the acute SAH. 
Similarly, specific mRNA isoforms in intracerebral hem-
orrhage and ischemic stroke of different etiologies were 
previously reported [29]. The functional significance of 
these transcriptional alterations remains unclear. ELF2 
(E74-like factor 2) plays an important role in lymphocyte 
development. Two ELF2 isoforms derived from alterna-
tive promotors have been shown to exert opposite effects 
on cell proliferation. Namely, ELF2B had a negative influ-
ence on cell cycle progression and survival and induced 
apoptosis, and these negative effects were dependent on 
the presence of the N-terminus [30]. Here, we found that 
some of the ELF2 transcripts had opposite directions 
of expression changes in acute SAH compared to the 
chronic phase. The isoform upregulated in RAA is built 
from the initial 7 exons, whereas the downregulated tran-
script, possesses the terminal 6–7 exons. Another iden-
tified gene with different isoform expression is ACBD6 
(acyl-coenzyme A binding domain-containing member 
6). It is expressed predominantly in hematopoietic pro-
genitor cells and is important for lipid homeostasis [31, 
32]. Here, only isoforms with alternative splicing affect-
ing the C-terminus, which contains ankyrin-repeat 
motifs, showed lower expression in RAA. These repeats 
mediate protein–protein interactions. For HEATR1 
(HEAT repeat-containing protein 1), we also found that 
distinct isoforms may have different expression levels in 
different periods after IA rupture. HEATR1 protein is 
involved in the regulation of ribosomal biogenesis [33]. 
Downregulation of HEATR1 causes G1-cell cycle arrest 
[34]. Here, one of the HEATR1 transcripts was downreg-
ulated among RAA patients. Mutations within ELF2 and 
HEATR1 were identified in T-cell leukemia/lymphoma 
patients [35].
The presented results demonstrated that IA rupture 
causes multidirectional alterations in transcriptomes 
of peripheral blood cells. In ischemic stroke, a stroke-
induced immunodeficiency syndrome is a recognized 
phenomenon, which involves reduced T-lymphocytes 
counts and enhanced apoptosis of immune cells in the 
spleen and thymus [36, 37]. Altogether, these results 
strongly suggest that the immune system responses to 
an acute vascular event are underlined by many com-
mon mechanisms. The significance of immunodepres-
sion is unclear. On the one hand, it is associated with 
more severe brain injury and an increased risk of infec-
tions. However, it could play a positive role in limiting 
the inflammatory response in the brain and reducing the 
immune reaction against brain-derived autoantigens [38]. 
Interestingly, analysis of alterations in cell numbers and 
transcripts levels suggest that changes in monocyte-spe-
cific transcripts are actively regulated and those related to 
lymphocytes depend on cell counts in acute SAH.
Our study has some potential limitations. One is the 
limited sample size and lack of validation of obtained 
results in another group of patients. However, to some 
extent, the present study is an extension of our previous 
work and the results are clearly parallel. We were able 
to confirm the specificity of the L/MN index. Next, for 
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the transcriptomics, we used total peripheral leukocytes. 
Analyses performed in specific cell subclasses would 
provide a more comprehensive insight into the systemic 
response to IA rupture. Such an approach would also 
require a substantially larger blood sampling, and a prob-
lem regarding how the cell sorting procedure (to isolate 
cell subpopulations) could influence gene expression 
remains. In addition, we are aware that our study favored 
inclusion of RAA patients admitted in relatively good 
clinical condition. For the flow cytometry procedures 
only freshly obtained blood samples within working 
hours of the laboratory were useful. Before any study-
related procedures were started we needed to obtained 
an informed consent—in almost all cases these consents 
were given by patients themselves. That means that 
patients admitted in the afternoon, in the evening, or at 
nights, holidays, etc. who required immediate interven-
tions could to be included into the study.
Conclusions
In summary, the results of this study demonstrated that IA 
rupture evokes a prominent systemic response clearly influ-
encing the transcription profiles of peripheral blood cells as 
well as the composition of mononuclear cells. A specific 
pattern of gene expression alteration found here suggests 
a depression of lymphocyte response and enhancement of 
monocyte activity. These alterations are seen both in the 
cellular composition and in the gene expression profiles.
Additional files
Additional file 1: Table S1. Validation of different biotypes of transcrip-
tional variants regulated in response to IA rupture. Selected transcriptional 
variants (from the list included in Additional file 4: Table S3) were validated 
by using qPCR. The results are presented as the fold change with respect 
to the control group with a standard error of the mean (n = 10 to 14). 
Significant differences in the main effects from one-way ANOVA for the 
clinical status factor.
Additional file 2: Table S2. The specific IA-altered transcriptional variants 
of genes used for L/MN index calculation. The L/MN index was calcu-
lated as the ratio of the mean folds of standardized expression levels of 
lymphocyte-related genes (BCL11B, CCR7, CD2, CD27, CD3D, CD3E, CD8A, 
and KLRB1) to those of monocyte-and-neutrophil-related genes (ANXA3, 
ARG1, CD14, GYG1, FCGR1A, FCGR2A, IRAK3, and MMP9). L = lymphocyte-
specific gene; M = monocyte-specific gene.
Additional file 3: Figure S1. Time-course of alterations in expression 
of BASP1-AS1 and SLC26A8 after the rupture of an intracranial aneurysm. 
Y-axis represents gene expression level for BASP1-AS1 and SLC26A8 
presented as log2 FPKM values. On x-axis mean expression level measured 
in RAA samples, levels from RAC samples collected at specific time points 
and mean level measured in C samples are presented, respectively. The 
association between gene expression and time period of sample collec-
tion after the rupture were measured by Spearman’s rank correlation coef-
ficient. The correlation coefficient was calculated as R = -0.76 (p < 0.0025) 
for BASP1-AS1 (ENST00000399760) and R = -0.72 (p = 0.0048) for SLC26A8 
(ENST00000486155).
Additional file 4: Table S3. ANOVA results of expression profiling of 
transcripts regulated in response to IA rupture in peripheral blood. A table 
summarizing the results of the one-way ANOVA (FDR < 0.001) for the clini-
cal status as the factor (RAA, RAC, C). The table contains the fold change of 
difference between the groups for each regulated transcript. Transcripts 
were annotated using the Ensembl gene database.
Additional file 5: Table S4. The results of the functional enrichment 
analyses performed with the Enrichr tool. WikiPathways, GO Biological 
processes, ChEA and GeneAtlas categories for the up- and downregulated 
genes in response to IA-rupture are included. The table consists of an 
enriched term, the number of input genes in the pathway (overlap), the p 
value (p < 0.05), the z score, the combined score (computed as logarithm 
from p value from the Fisher’s exact test multiplied by the z score of the 
deviation from the expected rank), and the names of overrepresented 
genes.
Additional file 6: Table S5. The results of pair-wise differential expression 
analysis of samples in each group using Cuffdiff. Three comparisons are 
presented: C vs RAA; C vs RAC, RAA vs RAC. At the transcript-level 148 dif-
ferential expressed units were identified (q-values < 0.05). The analyses at 
the levels alternative exon splicing and alternative promoter usage did not 
provide significant results.
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